IgG4-related systemic disease (IgG4-RSD) is an emerging clinical entity about which much 2 remains to be elucidated, in terms of its aetiology, pathogenesis, diagnosis, treatment and 
Küttner tumour [1, 4, 5] . One of the most important peculiarities of IgG4-RSD is that 7 involved lesions often mimic malignancies but respond well to steroid therapy [6] . The 8 epidemiologic information about IgG4-RSD is currently sparse, because it is still an 9 emerging clinical entity and a large number of patients probably remain under-diagnosed 10 [3]. As for AIP, a national-wide survey in Japan in 2002 reported that the prevalence was 11 estimated to be 0.82 per 100,000, predominantly seen in men over the age of 45 years 12 (male : female ratio was 2.85 : 1 in their study population) [7] . differentiate benign from malignant findings [10] [11] [12] . However, this technique is 17 increasingly recognized as useful for diagnosis, characterization, and monitoring of 18 4 response to therapy in patients with inflammatory disorders [13] . This article will provide 1 an overview of IgG4-RSD and the potential role of FDG PET/CT will be illustrated. 
Autoimmune pancreatitis and IgG4

5
AIP is a unique form of pancreatitis predominantly incident in elderly males in which 6 autoimmune mechanisms are thought to be involved in the pathogenesis [14] [15] [16] . AIP is 7 one of the major, well-studied constituents of IgG4-RSD. There exist well developed 8 consensus criteria for the diagnosis of AIP: Asian diagnostic criteria from the Japan-Korea 9 Symposium on AIP and HISTOR criteria from Mayo Clinic [16, 17] . The symptoms in 
16
AIP is morphologically characterized by irregular narrowing of the main pancreatic duct 17 and diffuse or segmental enlargement of the pancreas [19, 20] . One of the most 18 characteristic imaging features of AIP is a "sausage-like" enlargement of pancreas with 1 "capsule-like" rim, which reflects intense fibrosis around peripancreatic tissue (Fig. 1) 10 MD is a persistent symmetrical swelling of the lacrimal and salivary glands with non-11 neoplastic and non-infectious origins (Fig. 2) Concomitant lymphadenopathy is also common, which occasionally manifests as systemic (Fig. 3) ; MD as symmetric swelling of lacrimal and submandibular glands; and Whole-body FDG PET/CT provides excellent information about the distribution of disease.
13
It would be a useful tool for detecting systemic involvement in patients with IgG4-RSD.
14 Nakajo et al. reported that PET scans revealed intense FDG uptake by AIP in all six 15 patients and that abnormal FDG uptake by extrapancreatic lesions were observed in five of 16 the six patients [12] . Although it is hard to differentiate malignancy from inflammatory SUV was 5.3 in the early phase and 6.5 in the delayed phase) [11] . However, they stated 6 that multiple foci in the pancreas were significantly more often observed in AIP (8 of 15 7 cases) than in pancreatic cancer (1 of 19 cases). Also, hilar lymphadenopathy was 8 significantly more frequent in patients with AIP (9 of 15 cases) than in patients with 9 pancreatic cancer (3 of 26 cases). Concomitant FDG uptake in the lacrimal gland, salivary 10 gland, biliary duct, retroperitoneal space, and prostate were seen only in patients with AIP 11 in their study [11] . Therefore, it seems that concomitant FDG uptake in these organs may 12 support the diagnosis of AIP (Fig. 4) . The predominance of FDG PET/CT about the 
Guiding minimally invasive tissue diagnosis to support the diagnosis of IgG4-RSD
19
Intensity of FDG uptake cannot always distinguish between malignant and benign 1 disorders; however, it generally reflects glucose metabolism and thereby disease activity.
2
Therefore, FDG PET/CT can be a helpful adjunct for detecting an adequate biopsy site. conditions. In such cases, providing an adequate diagnosis of IgG4-RSD is made, the (Fig. 6) [58] . Actually, IgG4-RSD is often (Fig. 7) . The advantage of PET is that SUV is available as a Impaired exocrine function or other organ dysfunction is also a sign of disease relapse. The development of lymphoma during the follow-up of IgG4-RSD is occasionally 12 experienced (Fig. 8) . Takahasahi 
